Diagnostic News and Research

RSS

Dye reduction in diagnostic heart procedures: an interview with Mike McCormick, CEO Osprey Medical

Iodine based contrast media (dye) is radiopaque and is commonly used for diagnostic and interventional heart procedures. It allows physicians to see real time images of the heart vessels and treat any blockages.

3 Dec 2013

Toshiba’s MR technologies improve patient care, diagnostic accuracy

Clinicians can utilize MRI to diagnose more conditions with Toshiba America Medical Systems, Inc.'s advanced applications for its Vantage Titan™ MR systems.

3 Dec 2013

3T MRI scanner allows Polish scientists to perform structural and functional imaging of human brain

The Nencki Institute of Experimental Biology in Warsaw launches research programs, which require state-of-the-art magnetic resonance scanner.

3 Dec 2013

Reimbursement cuts for image-guided breast biopsies may reduce women's access to mammography

Drastic reimbursement cuts for image-guided breast biopsies, and other medical imaging techniques in the 2014 Medicare Fee Schedule Final Rule, may further reduce women's access to mammography and other breast cancer services. The Centers for Medicare and Medicaid Services directly cut imaging reimbursement every year since 2007. This, along with 12 Medicare imaging cuts in the last six years due to legislation, increasingly threatens patient care.

3 Dec 2013

Siemens Healthcare to introduce new angiography system at RSNA 2013

At the 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America, December 1-6 in Chicago, Siemens Healthcare (booth #1934, South Building/Lakeside Center at McCormick Place, Hall A) will introduce a new angiography system optimized for broad clinical utilization.

3 Dec 2013

Xagenic announces closing of $20 million Series B financing

Xagenic Inc., a molecular diagnostics company developing the first lab-free molecular diagnostic platform with a 20 minute time-to-result, today announced the close of a Series B financing totaling $20 million. The round was led by new investor Domain Associates, LLC, which was joined by existing investors including CTI Life Sciences Fund and the Ontario Emerging Technologies Fund.

2 Dec 2013

Healthcare providers can now improve diagnostic confidence with Toshiba's Kalare R&F digital X-ray

Healthcare providers can improve their diagnostic confidence with Toshiba America Medical Systems, Inc.'s more flexible Kalare R&F digital X-ray system. Featuring a new 17" x 17" dynamic flat panel detector (works-in-progress), the system provides clinicians with distortion-free, high-quality images.

2 Dec 2013

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing, today announces that it is launching a CE/IVD labeled MID kit for Illumina MiSeq together with three new germline mutation detection MASTRTM kits enabling the identification of individuals at risk for maturity onset diabetes of the young, autosomal dominant hypercholesterolemia, and hypertrophic cardiomyopathy.

2 Dec 2013

Science Translational Medicine editorial urges researchers to support the Affordable Care Act

An editorial by Harry P. Selker, MD, MSPH, William H. Frist, MD, and Stuart Altman, PhD, published in the November 27 issue of Science Translational Medicine says the Patient Protection and Affordable Care Act is an example of the role of experimentation in improving health at the public policy level.

2 Dec 2013

Royal Philips showcases EPIQ and AlluraClarity systems at RSNA 2013

Today, at the 99th Annual Meeting of the Radiological Society of North America in Chicago, Royal Philips showcases its EPIQ premium ultrasound system that combines an exceptional level of clinical performance, advanced system intelligence and intuitive design, and its AlluraClarity interventional X-ray system that provides high quality imaging for a comprehensive range of clinical procedures, achieving excellent visibility at low X-ray dose levels for patients of all sizes.

From Philips Healthcare 1 Dec 2013

New methods reduce mother-to-child transmission of HIV from 23.9% to 2.4% in Gipuzkoa

Miren Apilánez, researcher in the Department of Paediatrics of the UPV/EHU-University of the Basque Country, has studied the evolution that took place between 1984 and 2011 in paediatric HIV infection in Gipuzkoa. The development of methods to diagnose the disease coupled with increasingly more effective treatments have made it possible to reduce mother-to-child transmission (vertical transmission) from 23.9% to 2.4%, thus virtually eradicating infection in children.

30 Nov 2013

Diagnosing colonic polyps: an interview with Dr. Haili Wang, Metabolomic Technologies Inc. (MTI)

Colorectal cancer is a leading cause of death in North America, but it is preventable if found at the colonic polyp stage. Currently, only 39% of colorectal cancer cases in the US are diagnosed at an early and treatable stage.

28 Nov 2013

CPCs not powerful enough to be used as a single tool in diagnosis of acute myocardial infarction

Using chest pain characteristics (CPCs) specific to women in the early diagnosis of acute myocardial infarction (AMI, heart attack) in the emergency department does not seem to be supported by the findings of a study published by JAMA Internal Medicine, a JAMA Network publication.

27 Nov 2013

More than three-quarters of parents are willing to have their children participate in research

To improve healthcare for children, medical research that involves kids is a must. Yet, only five percent of parents say their children have ever participated in any type of medical research, according to a new University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health.

27 Nov 2013

Genetics and cardiovascular drugs: an interview with Nancy Lurker, CEO of PDI and Paul Kinnon, CEO of Transgenomic, Inc.

People inherit different versions of any particular gene, and some genes affect how patients process and metabolize medicines. This especially holds true for people with cardiovascular (CV) disease. They may be fast, slow or non-metabolizers and might also react badly (with serious adverse events) to certain drug therapies or not at all.

27 Nov 2013

FDA grants Orphan Drug Designation to CMC Contrast's CMC-001 MRI contrast media

CMC Contrast AB, a privately owned drug development company that is developing a targeted contrast agent for Magnetic Resonance Imaging (MRI), announced today that Orphan Drug Designation has been granted by the US Food and Drug Administration (FDA) for its liver specific contrast agent CMC-001.

27 Nov 2013

AB SCIEX launches IVD-MS Analyzer CE marked for general in vitro diagnostic use in Europe

Continuing to rapidly expand its presence in the clinical diagnostics field, AB SCIEX, a global leader in analytical technologies, today announced the launch of its AB SCIEX IVD-MS™ Analyzer CE marked for general in vitro diagnostic use in Europe.*

27 Nov 2013

International researchers report significant findings on vascular abnormality outside the brain

Studies on Alzheimer's disease and other forms of dementia have long focused on what's happening inside the brain. Now an international research team studying Alzheimer's and mild cognitive impairment is reporting potentially significant findings on a vascular abnormality outside the brain.

27 Nov 2013

BUSM & BMC win GCE grant to develop next-generation condom using nanotechnology

The department of radiology at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) is a Grand Challenges Explorations (GCE) winner, an initiative funded by the Bill & Melinda Gates Foundation.

26 Nov 2013

Bruker receives FDA clearance to market MALDI Biotyper CA System in the U.S.

Bruker Corporation today announced that it has been granted U.S. FDA clearance under Section 510(k) to market its MALDI Biotyper CA System in the United States for the identification of Gram negative bacterial colonies cultured from human specimens.

26 Nov 2013

Diagnostic News and Research

Dye reduction in diagnostic heart procedures: an interview with Mike McCormick, CEO Osprey Medical

Toshiba’s MR technologies improve patient care, diagnostic accuracy

3T MRI scanner allows Polish scientists to perform structural and functional imaging of human brain

Reimbursement cuts for image-guided breast biopsies may reduce women's access to mammography

Siemens Healthcare to introduce new angiography system at RSNA 2013

Xagenic announces closing of $20 million Series B financing

Healthcare providers can now improve diagnostic confidence with Toshiba's Kalare R&F digital X-ray

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Science Translational Medicine editorial urges researchers to support the Affordable Care Act

Royal Philips showcases EPIQ and AlluraClarity systems at RSNA 2013

New methods reduce mother-to-child transmission of HIV from 23.9% to 2.4% in Gipuzkoa

Diagnosing colonic polyps: an interview with Dr. Haili Wang, Metabolomic Technologies Inc. (MTI)

CPCs not powerful enough to be used as a single tool in diagnosis of acute myocardial infarction

More than three-quarters of parents are willing to have their children participate in research

Genetics and cardiovascular drugs: an interview with Nancy Lurker, CEO of PDI and Paul Kinnon, CEO of Transgenomic, Inc.

FDA grants Orphan Drug Designation to CMC Contrast's CMC-001 MRI contrast media

AB SCIEX launches IVD-MS Analyzer CE marked for general in vitro diagnostic use in Europe

International researchers report significant findings on vascular abnormality outside the brain

BUSM & BMC win GCE grant to develop next-generation condom using nanotechnology

Bruker receives FDA clearance to market MALDI Biotyper CA System in the U.S.

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News